← Patent-cliff monitor Loss of exclusivity December 2042 latest FDA-listed patent expiry
Company AXSOME MALTA LTD
Drug detail Brand name SUNOSI Active ingredient SOLRIAMFETOL HYDROCHLORIDE Strength EQ 150MG BASE Dosage form TABLET Route ORAL Modality Small molecule FDA approval June 2019 Marketing status RX
Listed patents Patent Expires Type 12036194 December 2042 use U-3693 12102609 December 2042 use U-3693 11793776 December 2042 use U-3693 11872203 December 2042 use U-3693 12064411 December 2042 use U-3693 11771667 December 2042 use U-3693 11771666 December 2042 use U-3693 11779554 December 2042 use U-3693 12005036 December 2042 use U-3693 12090126 December 2042 use U-3693 11872204 December 2042 use U-3693 11850226 March 2040 use U-3775 11850228 March 2040 use U-3775 11857528 March 2040 use U-3521 11986454 March 2040 use U-3775 11160779 March 2040 use U-3521 11986455 March 2040 use U-3521 11969404 March 2040 use U-3892 12194016 March 2040 use U-4106 11839599 March 2040 use U-3764 11839598 March 2040 use U-3765 11850227 March 2040 use U-3775 11560354 March 2039 product 12384743 November 2038 substance, product 10959976 June 2038 use U-3151 11648232 June 2038 use U-3602 11865098 June 2038 use U-2548 10912754 June 2038 use U-3082 10195151 September 2037 product 10512609 September 2037 use U-2548 12390419 September 2037 product 11998639 September 2037 product 11439597 September 2037 product 8440715 June 2031 use U-2548 11753368 June 2026 use U-2548 12209059 June 2026 use U-2548 10351517 June 2026 use U-2548 9604917 June 2026 use U-2548 8877806 June 2026 use U-2548
Regulatory exclusivity Code Expires ODE-254 June 2026
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.